75
Views
12
CrossRef citations to date
0
Altmetric
Original Research

LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p

, , &
Pages 1113-1121 | Published online: 05 Feb 2021

References

  • Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomark Prev. 2017;26(4):444–457. doi:10.1158/1055-9965.EPI-16-0858
  • Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809–815. doi:10.1158/1055-9965.EPI-16-088928522448
  • Martos T, Casadevall D, Albanell J. Circulating tumor cells: applications for early breast cancer. Adv Exp Med Biol. 2020;1220:135–146.32304084
  • Mei J, Hao L, Wang H, et al. Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell Prolif. 2020;53(5):e12801. doi:10.1111/cpr.1280132249490
  • Zhang L, Dong X, Yan B, Yu W, Shan L. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1. Cell Death Dis. 2020;11(7):542. doi:10.1038/s41419-020-2707-632681092
  • Li G, Qian L, Tang X, Chen Y, Zhao Z, Zhang C. Long non‑coding RNA growth arrest‑specific 5 (GAS5) acts as a tumor suppressor by promoting autophagy in breast cancer. Mol Med Rep. 2020;22(3):2460–2468. doi:10.3892/mmr.2020.1133432705220
  • Guo F, Zhu X, Zhao Q, Huang Q. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R. Int J Mol Med. 2020;46(3):989–1002. doi:10.3892/ijmm.2020.466632705168
  • Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21. doi:10.1038/nrg360624296535
  • Wu H, Gu J, Zhou D, et al. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ. J Cell Mol Med. 2020. doi:10.1111/jcmm.15487
  • Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J. LncRNA DLX6-AS1 contributes to epithelial-mesenchymal transition and cisplatin resistance in triple-negative breast cancer via modulating Mir-199b-5p/Paxillin axis. Cell Transplant. 2020;29:963689720929983. doi:10.1177/096368972092998332686982
  • Qi H, Xiao Z, Wang Y. Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis. Onco Targets Ther. 2019;12:6981–6990. doi:10.2147/OTT.S21458831695413
  • Ding J, Zhao J, Huan L, et al. LINC00665 increases the malignancy through activating PKR/NF-κB pathway in hepatocellular carcinoma. Hepatology. 2020. doi:10.1002/hep.31195
  • Ji W, Diao YL, Qiu YR, Ge J, Cao XC, Yu Y. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death Dis. 2020;11(1):16. doi:10.1038/s41419-019-2213-x31907362
  • Okazaki Y, Furuno M, Kasukawa T, et al.; FANTOM Consortium; RIKEN Genome Exploration. Research Group Phase I & II Team. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420(6915):563–573.12466851
  • Zhou JL, Zou L, Zhu T. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT. Eur Rev Med Pharmacol Sci. 2020;24(6):3097–3104. doi:10.26355/eurrev_202003_2067432271427
  • Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature1298624429633
  • Jiang X, Jiang M, Xu M, Xu J, Li Y. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer. Pathol Res Pract. 2019;215(5):900–904. doi:10.1016/j.prp.2019.01.03530732916